Batoclimab

7 trials Orphan designation

Filter these 7 trials by condition, phase, country and more.

Open in Search →

7 Registered trials

0 Recruiting

7 Completed trials

1 Sponsors

16 Countries

Phase III

Phase II

Phase III: 4 Phase II: 3

Oversight events:

14 temporary halts 2 urgent safety measures across 3 trials

View oversight register →

Sponsors using this IMP

Immunovant Sciences GmbH 7

All trials

7 total

A Phase 2b Study to Assess the Safety and tolerability of Batoclimab in Patients with CIDP Ended

2024-518364-12-00 Phase II 10 countries Immunovant Sciences GmbH
Extension Study to Assess Batoclimab in Participants with TED. Ended

2024-512650-21-00 Phase III 7 countries Immunovant Sciences GmbH
Phase 3 Study to Assess Batoclimab in Participants with Active Thyroid Eye Disease. Ended

2024-512648-45-00 Phase III 3 countries Immunovant Sciences GmbH
Phase 2b Study to Assess Efficacy and Safety of Batoclimab in Adult Participants with Active CIDP. Ended

2024-512646-42-00 Phase II 14 countries Immunovant Sciences GmbH
Graves' disease is an immune system disorder that results in the overproduction of thyroid hormones. Ended

2024-512647-23-00 Phase II 1 country Immunovant Sciences GmbH
Phase 3 Study to Assess Batoclimab in Participants with Active Thyroid Eye Disease Ended

2024-512649-18-00 Phase III 6 countries Immunovant Sciences GmbH
Phase 3 Study to Assess Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants with Generalized Myasth… Ended

2024-512258-91-00 Phase III 6 countries Immunovant Sciences GmbH

Showing 1–7 of 7 trials

← All drugs A–Z